All

API

FDF

Price

Services

Excipients

Enquiries

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

refresh

×

FILTER DATA :

News Type

Company

Product Type

Deal Size

Upfront Payment

refresh

Product Type

Companies

Intravacc

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Palestine

Post An Enquiry

CPhI India 2021

Participation Not Confirmed

Update your events

Intravacc Publishes Positive Phase I Shigella Conjugate Vaccine Data

Contact the Supplier

Lead Product(s): SF2a-TT15

Therapeutic Area: Infections and Infectious Diseases Product Name: SF2a-TT15

Highest Development Status: Phase I Product Type: Vaccine

Partner/Sponsor/Collaborator: Institut Pasteur

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable November 17, 2020

Details:

The clinical study in healthy adults shows that the vaccine (SF2a-TT15) is well tolerated and immunogenic. Intravacc developed a production process for this conjugate vaccine, manufactured the GMP batch and did stability testing and batch release.

Intravacc

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Palestine

Post An Enquiry

CPhI India 2021

Participation Not Confirmed

Update your events

Intravacc Reports Positive Data from Phase I Trial of RSV Vaccine

Contact the Supplier

Lead Product(s): RSVDG vaccine

Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

Highest Development Status: Phase I Product Type: Vaccine

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 18, 2020

Details:

The vaccine candidate was observed to trigger immunogenicity following nasal administration in healthy adults aged 18 to 50. Investigators also reported the candidate to be safe and well-tolerated.